Literature DB >> 28341411

Oligoprogression: What Radiologists Need to Know About This Emerging Concept in Cancer Therapeutic Decision-making.

Steven P Rowe1, Phuoc T Tran2, Elliot K Fishman3, Pamela T Johnson3.   

Abstract

Keywords:  Cancer imaging; focal therapy; oligoprogression; oligoprogressive

Year:  2017        PMID： 28341411     DOI： 10.1016/j.acra.2016.12.018

Source DB:  PubMed          Journal:  Acad Radiol        ISSN： 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  2 in total

1.  Long-term response to avelumab and management of oligoprogression in Merkel cell carcinoma: A case report.

Authors:  Inês Leão; Joana Marinho; Telma Costa
Journal:  World J Clin Cases       Date:  2021-06-26       Impact factor: 1.337

2.  Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5.

Authors:  Robert Olson; Mitchell Liu; Alanah Bergman; Sonya Lam; Fred Hsu; Benjamin Mou; Tanya Berrang; Ante Mestrovic; Nick Chng; Derek Hyde; Quinn Matthews; Chad Lund; Daniel Glick; Howard Pai; Parminder Basran; Hannah Carolan; Boris Valev; Shilo Lefresene; Scott Tyldesley; Devin Schellenberg
Journal:  BMC Cancer       Date:  2018-10-04       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.